Back to search

Ireland· IE-PA-PPA1463/177/001

Campral EC 333 mg Gastro-resistant tablets

A acamprosate product containing acamprosate calcium, registered in Ireland by IMED Healthcare Ltd.,. The same ATC class is registered in 14 of our 19 countries.

ATC N07BB03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedCampral EC 333 mg Gastro-resistant ta…ATCN07BB03REGISTER NO.IE-PA-PPA1463/177/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Acamprosate is registered in 14 of 19 countries.

Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Acamprosate · ATC N07BB03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acamprosate costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Acamprosate · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.37
  • IT Italy$2.75
  • FR France$1.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Acamprosate calcium
Manufacturer
IMED Healthcare Ltd.,
Country
Ireland (IE)
ATC code
N07BB03
ATC class
Acamprosate
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PPA1463/177/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for acamprosate.

Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acamprosate · interactions on record

19 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Acamprosate in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acamprosate products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Campral
  • Belgium · Campral
  • Czechia · Campral
  • Germany · Campral
  • Spain · Campral
  • France · Acamprosate Biogaran, Acamprosate Viatris
  • United Kingdom (Northern Ireland) · Acamprosate Generics [uk] Ltd, Acamprosate Strandhaven Somex Pharma
  • Italy · Campral
  • Luxembourg · Campral
  • Netherlands · Campral
  • Norway · Campral
  • Poland · Campral
  • Portugal · Campral
  • Sweden · Akamprosat Viatris, Campral
  • Slovakia · Acamprosat Viatris, Campral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eba5bcbd-d03a-49ef-8cbc-7a26bba553a6
GET /v1/drugs/eba5bcbd-d03a-49ef-8cbc-7a26bba553a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gastro-resistant tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N07BB",
    "N07BB03"
  ],
  "strength": null,
  "pa_number": "PPA1463/177/001",
  "substances": [
    "Acamprosate calcium"
  ],
  "legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
  "market_info": "Unknown",
  "authorised_at": "02/07/2021",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about acamprosate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.